Ultragenyx Pharmaceutical (RARE) Inventory Average (2018 - 2026)

Ultragenyx Pharmaceutical (RARE) has 9 years of Inventory Average data on file, last reported at $53.5 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 17.54% year-over-year to $53.5 million in Q1 2026; TTM through Mar 2026 was $53.5 million, a 17.54% increase from a year earlier, with the FY2025 full-year figure at $48.5 million, up 22.83% from the prior year.
• Inventory Average for Q1 2026 stood at $53.5 million, up from $52.1 million in the prior quarter.
• Over the last five years, Inventory Average for RARE reached as high as $53.5 million in Q1 2026 and fell as low as $17.0 million in Q1 2022.
• Historically, Inventory Average has averaged $35.6 million across 5 years, with a median of $34.9 million in 2024.
• Across the five-year window, Inventory Average soared 56.82% in 2023 and grew 17.54% in 2026, its largest moves.
• Year by year, Inventory Average stood at $24.3 million in 2022, then jumped by 35.29% to $32.9 million in 2023, then surged by 34.31% to $44.2 million in 2024, then advanced by 17.96% to $52.1 million in 2025, then gained by 2.69% to $53.5 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $53.5 million in Q1 2026, $52.1 million in Q4 2025, and $49.3 million in Q3 2025.